Dexamethasone-suppressible hyperaldosteronism: Pathophysiology, clinical aspects, and new insights into the pathogenesis
- 1 May 1987
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 65 (10) , 437-444
- https://doi.org/10.1007/bf01712834
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- EFFECTS OF NALOXONE ON THE PITUITARY-ADRENAL AXIS IN PATIENTS WITH DEXAMETHASONE-SUPPRESSIBLE HYPERALDOSTERONISMClinical Endocrinology, 1987
- Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?Hypertension, 1986
- Hypertensive potency of 18-oxocortisol in the rat.Hypertension, 1986
- Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.Hypertension, 1984
- Evidence for the role of kinins in the acute antihypertensive effect of captopril in low-renin hypertension.Japanese Heart Journal, 1984
- Relation of Blood Pressure with Body and Plasma Electrolytes in Conn??s SyndromeJournal Of Hypertension, 1983
- Glucocorticoid-Suppressible Hyperaldosteronism: A Clue to the Missing Hormone?New England Journal of Medicine, 1981
- Anomalous Postural Aldosterone Response in Glucocorticoid-Suppressible HyperaldosteronismNew England Journal of Medicine, 1981
- AUTOSOMAL DOMINANT TRANSMISSION AND ABSENCE OF HLA LINKAGE IN DEXAMETHASONE SUPPRESSIBLE HYPERALDOSTERONISMThe Lancet, 1980
- Clinical, biochemical and pathological features of low-renin (“primary”) hyperaldosteronismAmerican Heart Journal, 1978